Avadel Pharmaceuticals
AVDLAvadel Pharmaceuticals plc NASDAQ: AVDL, is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring ne …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Avadel Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/16/2024 | Buy | Mchugh, Thomas S. | Chief Financial Officer | $14.5 | $29,000 |
| 12/28/2023 | Sell | Mccamish, Mark Anthony | Director | $14.5 | $1,089,750 |
| 8/14/2023 | Buy | Mchugh, Thomas S. | Chief Financial Officer | $14.5 | $28,900 |
| 8/11/2023 | Sell | Mccamish, Mark Anthony | Director | $14.9 | $432,614 |
| 8/10/2023 | Buy | Divis, Gregory J. | Chief Executive Officer | $13.2 | $131,997 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)